Lexeo Therapeutics
LXEO
LXEO
54 hedge funds and large institutions have $362M invested in Lexeo Therapeutics in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
25.96% more ownership
Funds ownership: 60.73% → 86.69% (+26%)
Holders
54
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$20.7M | |
| 2 | +$20.7M | |
| 3 | +$10.4M | |
| 4 |
Millennium Management
New York
|
+$8.08M |
| 5 |
BlackRock
New York
|
+$7.73M |
Top Sellers
| 1 | -$2.01M | |
| 2 | -$670K | |
| 3 | -$459K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$346K |
| 5 |
Legal & General Group
London,
United Kingdom
|
-$222K |